Director Michael Forer filed a Form 4 with the SEC on August 13, 2026, disclosing the acquisition of 102,202 share options in GH Research PLC (NASDAQ:GHRS) on August 11, 2026.
Director Duncan Moore of GH Research PLC filed a Form 4 on August 13, 2026, disclosing the acquisition of 2,202 share options in the company on August 11, 2026.
Diego Viglianco, Executive Vice President and Chief Information Officer of EVERTEC, Inc. (NYSE:EVTC), filed a Form 4 on August 13, 2026, reporting the sale of 27,570 shares of common stock on August 12, 2026.
A Form 4 filed with the SEC on August 13, 2026, discloses that Aldo J. Polak, a director of EVERTEC, Inc. (NYSE:EVTC), sold 1,000 shares of common stock on August 11, 2026.
Bren D. Higgins, Executive Vice President and Chief Financial Officer of KLA Corp, filed a Form 4 on August 13, 2026, reporting the sale of 31,500 shares of KLA common stock on August 12, 2026.
A Form 4 filed with the SEC on August 13, 2026, by Matthew Gilman as power of attorney for Elizabeth Hamren, a director of Hasbro, Inc. (NASDAQ:HAS), discloses two open-market sales of Hasbro common stock on August 4 and August 7, 2026.
Director John R. Stuelpnagel filed a Form 4 with the SEC on August 13, 2026, disclosing the sale of 20,000 shares of 10x Genomics, Inc. Class A Common Stock on August 11, 2026.
A Statement of Changes in Beneficial Ownership was filed on August 13, 2026, disclosing that Felicia Alvaro, a director of McGraw Hill, Inc. (NYSE:MH), received a grant of restricted stock units on August 11, 2026.
Director Steven Reinemund filed a Form 4 with the SEC on August 13, 2026, disclosing the acquisition of 16,086 restricted stock units of McGraw Hill, Inc. (NYSE:MH) on August 11, 2026.
A Form 4 filed on August 13, 2026, reports that Jonathan Simon Allen, a director of McGraw Hill, Inc. (NYSE:MH), received a grant of 16,086 restricted stock units on August 11, 2026.